Methylamine and benzylamine induced hypophagia in mice: Modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels

British Journal of Pharmacology

Volumn 134, Issue 4, 2001, Pages 880-886

  Pirisino, R ^a   Ghelardini, C ^a   Banchelli, G ^a   Galeotti, N ^a   Raimondi, L ^a  

^a Department of Preclinical and Clinical Pharmacology ^*  (Italy)

Author keywords

Antisense oligodeoxyribonucleotide; Food consumption; Kv1.1; Methylamine; Semicarbazide sensitive benzylamine oxidases

Indexed keywords

AMMONIUM CHLORIDE; AMPHETAMINE; BENZYLAMINE; CHARYBDOTOXIN; CLORGYLINE; GLIQUIDONE; METHYLAMINE; NICOTINE; POTASSIUM CHANNEL BLOCKING AGENT; SELEGILINE; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANOREXIGENIC ACTIVITY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENTIATION; FOOD INTAKE; HYPOPHAGIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALLYL COMPOUNDS; AMMONIUM CHLORIDE; AMPHETAMINE; ANIMALS; ANOREXIA; BEHAVIOR, ANIMAL; BENZYLAMINE OXIDASE; BENZYLAMINES; CHARYBDOTOXIN; DNA, ANTISENSE; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ENZYME INHIBITORS; GUANIDINES; INJECTIONS, INTRAVENTRICULAR; KV1.1 POTASSIUM CHANNEL; MALE; METHYLAMINES; MICE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; PROPYLAMINES; SEMICARBAZIDES; SULFONYLUREA COMPOUNDS; TETRAETHYLAMMONIUM;

EID: 0034750486     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704316     Document Type: Article

References (39)

1. Potassium channels in nervous tissue
2. Benzylamine-related compounds stimulate rat vas deferens neurotransmission and potentiate memory in the mouse acting as potassium channel blockers
3. Selective inhibition of amine oxidases differently potentiate the hypophagic effect of benzylamine in mice
4. Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase
5. Semicarbazide-sensitive amine oxidases: Some biochemical properties and general considerations
6. 24)
7. Pathogenesis, and treatment of portal-systemic encephalopathy: An update
8. Semicarbazide-sensitive amine oxidase (SSAO) from human and bovine cerebrovascular tissues: Biochemical and immunohistological characterization
9. A family of three mouse potassium channel genes with intronless coding regions
10. An antisense oligodeoxynucleotide to μ-opioid inhibits μ-opioid receptor agonist-induced analgesia in rats
11. The pharmacology of potassium channels and their therapeutic potential
12. The enzymatic systems involved in the mammalian metabolism of methylamine
13. Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5-HT in the striatum of conscious rats
14. The pharmacology of ATP-sensitive potassium channels
15. Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: Vascular cytoprotection in diabetes mellitus
16. Age-dependent effects of the 2′-methyl analog of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Prevention by inhibitors of monoamine oxidase B
17. Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like K + channel
18. Effect of K + channel modulation on mouse feeding behaviour
19. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse
20. + channels in the central nervous system
21. Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat
22. Members of a mouse subfamily of genes encoding voltage-gated potassium channel subunits from heteromultimers when co expressed in Venous oocytes
23. Ammonia blockade of intestinal epithelial K + conductance
24. Inhibition of delayed rectifier K + channels by dexfenfluramine (Redux)
25. Transgenic approach to the study of body weight regulation
26. A benzylamine oxidase distinct from monoamine oxidase B. Widespread distribution in man and rat
27. The enhanced daily excretion of urinary methylamine in rats treated with semicarbazide or hydralazin may be related to the inhibition of semicarbazide-sensitive amine oxidase activities
28. Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: Correlation with body mass index and serum triglyceride
29. Nicotine's effect on hypothalamic neurotransmitters and appetite regulation
30. Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells
31. Hypothalamic infusions of amphetamine increase serotonin, dopamin and norepinephrine
32. Calcium modulatory properties of 2,6-dibutylbenzylamine (B25) in rat isolated vas deferens, cardiac and smooth muscle preparations
33. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta
34. Intracellular enhancement of intact antisense oligonucleotide steady-state levels by cationic lipids
35. Metabolism and toxicity of aliphatic amines
36. Structure and function of cardiac potassium channels
37. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes
38. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: Implications for advanced glycation and diabetic complications
39. Increase in human exposure to methylamine precursors of N-nitrosamines after eating fish